The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
<p><b>Introduction:</b> The COVID-19 pandemic had collateral effects on many health systems. Cancer screening and diagnostic tests were postponed, resulting in delays in diagnosis and treatment. This study assessed the impact of the pandemic on screening, diagnostics and incidence...
Main Authors: | Barclay, NL, Pineda Moncusí, MP, Jödicke, AM, Prieto-Alhambra, D, Raventós, B, Newby, D, Delmestri, A, Man, WY, Chen, X, Català, M |
---|---|
Other Authors: | The OPTIMA Consortium |
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2024
|
Similar Items
-
The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
by: Nicola L. Barclay, et al.
Published: (2024-03-01) -
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study
by: Barclay, NL, et al.
Published: (2024) -
Incidence, prevalence, and survival of prostate cancer in the UK
by: Tan, EH, et al.
Published: (2024) -
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study
by: Nicola L. Barclay, et al.
Published: (2024-06-01) -
Risk of falls following the initiation of antihypertensives in the elderly: a self-controlled case series in the UK
by: Jödicke, AM, et al.
Published: (2021)